Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis

ClinicalTrials.gov ID: NCT06550076

Public ClinicalTrials.gov record NCT06550076. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 4:19 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Open-Label Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of TAK-279 in Subjects With Moderate-to-Severe Plaque Psoriasis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main aim of this study is to check the side effects of TAK-279 and how well it is tolerated in participants with moderate-to-severe plaque psoriasis. All participants will be assigned to study treatments of TAK-279 and will be treated with TAK-279 if the participants meet the study rules. Participants will be in the study for up to 217 weeks, including up to 35 days for the screening period, 52 weeks (Part A) up to 156 additional weeks (Part B) study treatment and 4 weeks follow up period. During the study, participants will visit their study clinic multiple times.

Study identification

NCT ID
NCT06550076
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Takeda
Industry
Enrollment
2,099 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 4, 2024 (Actual)
Primary completion
Aug 5, 2029 (Estimated)
Completion
Aug 5, 2029 (Estimated)
Last update posted
Jun 2, 2026

2024 – 2029

United States locations

U.S. sites
74
U.S. states
25
U.S. cities
65
Facility City State ZIP Site status
Total Dermatology Birmingham Alabama 35205 —
University of Alabama Hospital - Whitaker Clinic - Birmingham Alabama 35233-2110 —
Cahaba Dermatology Skin Health Center Hoover Alabama 35244-2111 —
Medical Dermatology Specialists Phoenix Arizona 85006 —
Saguaro Dermatology Associates, LLC - Probity - PPDS Phoenix Arizona 85008-3884 —
Noble Clinical Research Tucson Arizona 85704 —
Johnson Dermatology Clinic Fort Smith Arkansas 72916-6103 —
Burke Pharmaceutical Research Hot Springs Arkansas 71913-6475 —
Zenith Research, Inc. Beverly Hills California 90212 —
First OC Dermatology Research Inc. Fountain Valley California 92708 —
Center for Dermatology Clinical Research Fremont California 94538 —
Long Beach Research Institute Long Beach California 90805 —
Metropolis Dermatology Downtown LA - Probity - PPDS Los Angeles California 90017-5310 —
UCLA University of California Los Angeles Los Angeles California 90024 —
Northridge Clinical Trials Northridge California 91325-4122 —
UC Davis Dermatology Clinic Sacramento California 95816-3370 —
TCR Medical Corporation San Diego California 92123-1523 —
University Clinical Trials San Diego California 92123 —
Dermatology Institute and Skin Care Center Santa Monica California 90404-2216 —
UNISON Clinical Trials (Shahram Jacobs md inc.) Sherman Oaks California 91403 —
Driven Research LLC Coral Gables Florida 33134-3901 —
Revival Research Corporation - Florida - ClinEdge - PPDS Doral Florida 33122-1902 —
FXM Clinical Research Ft. Lauderdale, LLC Fort Lauderdale Florida 33308-5211 —
Direct Helpers Medical Center Hialeah Florida 33012 —
Florida Academic Centers Research Miami Florida 33136-1003 —
FXM Clinical Research Miami, LLC Miami Florida 33175-3582 —
San Marcus Research Clinic Inc Miami Lakes Florida 33014 —
FXM Research Miramar Miramar Florida 33027-4714 —
Renstar Medical Research -21 NE 1st Ave Ocala Florida 34470 —
Lenus Research & Medical Group Sweetwater Florida 33172 —
Advanced Clinical Research Institute (ACRI) - Florida Tampa Florida 33607-6429 —
Divine Dermatology and Aesthetics, LLC Atlanta Georgia 30315-2042 —
Marietta Dermatology & The Skin Cancer Center - Marietta Marietta Georgia 30060-7902 —
Advanced Medical Research, PC Sandy Springs Georgia 30328 —
Georgia Skin and Cancer Clinic Savannah Georgia 31419-1768 —
Leavitt Clinical Research Idaho Falls Idaho 83404-8322 —
Arlington Dermatology Rolling Meadows Illinois 60008-3811 —
NorthShore Medical Group Dermatology - Skokie Skokie Illinois 60077-1049 —
DS Research - 1005 E. Lewis & Clark Pkwy Indiana Location Clarksville Indiana 47129-2201 —
Dawes Fretzin Clinical Research Group, LLC Indianapolis Indiana 46250 —
Skin Sciences, PLLC Louisville Kentucky 40217-1444 —
Dermatology Specialists Research - 3810 Springhurst Blvd Louisville Kentucky 40241-6162 —
Lawrence J Green, MD LLC Rockville Maryland 20850 —
University of Michigan Hospital - 1500 E Medical Center Dr Ann Arbor Michigan 48109-5360 —
Oakland Hills Dermatology - 3400 Auburn Rd Auburn Hills Michigan 48326-3396 —
Revival Research Corporation - ClinEdge Troy Michigan 48084-3536 —
Minnesota Clinical Study Center New Brighton Minnesota 55112 —
Skin Specialists PC Omaha Nebraska 68144 —
Henderson Clinical Trials Henderson Nevada 89052 —
Dartmouth Hitchcock Medical Center - Old Etna Rd Lebanon New Hampshire 03766-1937 —
ALLCUTIS Research, LLC. Portsmouth New Hampshire 03801 —
Psoriasis Treatment Center of Central New Jersey East Windsor New Jersey 08520 —
Sadick Research Group New York New York 10075-0385 —
Montefiore AOA - BRANY The Bronx New York 10467 —
Accellacare of Cary Cary North Carolina 27518 —
The Skin Surgery Center for Clinical Research - Objective Health - PPDS Winston-Salem North Carolina 27103-7109 —
Bexley Dermatology Research - Probity - PPDS Bexley Ohio 43209 —
Wright State Physicians Fairborn Ohio 45324 —
Apex Clinical Research Center Mayfield Heights Ohio 44124-4005 —
Oregon Medical Research Center PC Portland Oregon 97201 —
University of Pittsburgh Medical Center-3601 5th Ave Pittsburgh Pennsylvania 15213-3403 —
Cumberland Skin Center for Clinical Research - Objective Health - PPDS Hermitage Tennessee 37076-3497 —
International Clinical Research US LLC Murfreesboro Tennessee 37130-2450 —
Arlington Research Center Arlington Texas 76011-3800 —
Bellaire Dermatology Associates Bellaire Texas 77401-3505 —
UT Physicians Dermatology - Bellaire Station Bellaire Texas 77401 —
Modern Research Associates Dallas Texas 75231-6077 —
North Texas Center for Clinical Research Frisco Texas 75034 —
San Antonio San Antonio Texas 78213-2250 —
Texas Dermatology and Laser Specialists-San Antonio-7703 Floyd Curl Dr San Antonio Texas 78218-3128 —
Dermatology Clinical Research Center of San Antonio San Antonio Texas 78229-3409 —
Houston Center for Clinical Research, LLC Sugar Land Texas 77479-1001 —
Center For Clinical Studies, LTD. LLP - 451 N Texas Ave Webster Texas 77598-4927 —
Virginia Clinical Research - 6160 Kempsville Cir Norfolk Virginia 23507 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 204 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06550076, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 2, 2026 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06550076 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →